Abstract
We have isolated human cDNA and genomic clones of a gene termed p57KIP2, which is related to the p21WAF1 and p27KIP1 genes that encode inducible inhibitors of cyclin-dependent kinase activity. The p57 gene contains three GC-rich introns of 166 bp, 566 bp, and 83 bp, and two of the four exons correspond to coding regions. Alternative splicing generates the heterogeneity in the translational initiations. As this gene has been localized to chromosomal band l 1p15.5, a region thought to be the location of a tumor suppressor gene(s) for carcinomas of the breast, bladder, and liver, we have examined a large number of tumors for genetic alterations of p57. Although no somatic mutation has been detected, we have found several normal variations in this gene, including four types of 12-bp in-frame deletions in the proline/alanine repeating domain, in which nearly 40 motifs, viz., 5′-CCGGCC-3′, are tandemly repeated.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bullrich F, MacLachlan TK, Sang N, Druck T, Veronese ML, Allen SL, Chiorazzi N, Koff A, Heubner K, Croce CM, Giordano A (1995) Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdkinhibitor, p27Kip1, to regions involved in human cancer. Cancer Res 55: 1199–1205
Caskey CT, Pizzuti A, Fu Y-H, Fenwick Jr RG, Nelson D (1992) Triplet repeat mutations in human disease. Science 256: 784–789
Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform. Anal Biochem 162:156–159
El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B (1993) WAFT, a potential mediator of p53 tumor suppression. Cell 75: 817–825
Fearon ER, Feinberg AP, Hamilton SR, Vogelstein B (1985) Loss of genes on the short arm of chromosomel 1 in bladder cancer. Nature 318: 377–380
Flores-Rozas H, Kelman Z, Dean FB, Pan ZQ, Harper JW, Elledge SJ, O'Donell M, Hurwitz J (1994) Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase and holoenzyme. Proc Natl Acad Sci USA 91: 8655–8659
Fujimori M, Tokino T, Hino O, Kitagawa T, Imamura T, Okamoto E, Mitsunobu M, Ishikawa T, Nakagama H, Harada H, Yagura M, Matsubara K, Nakamura Y (1991) Allelotype study of primary hepatocellular carcinoma. Cancer Res 51: 89–93
Gu Y, Turck CW, Morgan DC (1993) Inhibition of CDK2 activity in vivo by an associated 20 K regulatory subunit. Nature 366: 707–710
Guan K-L, Jenkins CW, Li Y, Nichols MA, Wu X, O'Keefe CL, Matera AG, Xiong Y (1994) Growth suppression by p18, a p16INK4/MTS 1 and pl4lNK4/MTS-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 8: 2939–2952
Han H-J, Maruyama M, Baba S, Park J-G, Nakamura Y (1995) Genomic structure of human mismatch repair gene, hMLHI, and its mutation analysis in patients with hereditary non-polyposis colorectal cancer (HNPCC). Hum Mol Genet 4: 237–242
Hannon GJ, Beach D (1994) p15INK4b is a potential effector of cell cycle arrest mediated by TGF-b. Nature 371: 257–261
Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993) The p21 cdk-interacting protein Cipl is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805–816
Hunter T, Pines J (1994) Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell 79: 573–582
Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD, Clark WH, Tucker MA, Dracopoli NC (1994) Germline p16 mutations in familial melanoma. Nature Genet 8: 15–21
Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS III, Johnson BE, Skolnick MH (1994a) A cell cycle regulator involved in genesis of many tumor types. Science 264: 436–440
Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, Hussry C, Tran T, Miki Y, Weaver-Feldhaus J, McClure M, Aitken JF, Anderson DE, Bergman W, Frants R, Goldgar DE, Green A, MacLennan R, Martin NG, Meyer LJ, Youl P, Zone JJ, Skolnick MH, Cannon-Albright LA (1994b) Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p susceptibility locus. Nature Genet 8: 23–26
Kawamata N, Morosetti R, Miller CW, Park D, Spirin KS, Nakamaki T, Takeuchi S, Hatta Y, Simpson J, Wilczynski S, Lee YY, Bartram CR, Koeffler HP (1995) Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip I in human malignancies. Cancer Res 55: 2266–2269
Lee M-H, Reynisdottir I, Massague J (1995) Cloning of p57Kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 9: 639–649
Li R, Waga S, Hannon GJ, Beach D, Stillman B (1994) Differential effects by the p21 CDK inhibitor on PCNA dependent DNA replication and repair. Nature 371: 534–537
Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M, Willson JKV (1995) Inactivation of the type II TGF-b receptor in colon cancer cells with microsatellite instability. Science 268:1336–1338
Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, Elledge SJ (1995) p57KIP2, a structurally distinct member of the p21CIPl Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev. 9: 650–662
Mossese S, Ozcelik H, Lee PD, Malkin D, Bull SB, Andrulis IL (1995) Two variants of the CIPl/WAF1 gene occur together and are associated with human cancer. Hum Mol Genet 4: 1089–1092
Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753–756
Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR (1994) Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211: 90–98
Pietenpol JA, Bohlander SK, Sato Y, Papadopoulos N, Liu B, Friedman C, Trask BJ, Roberts JM, Kinzler KW, Rowley JD, Vogelstein B (1995) Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemia. Cancer Res 55: 1206–1210
Polyak K, Lee M-H, Erdjument-Bromage H, Koff A, Tempst P, Roberts JM, Massague J (1994) Cloning of p27Kip1, a cyclindependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78: 59–66
Ponce-Castaneda MV, Lee M-H, Latres E, Polyak K, Lacombe L, Montgomer K, Mathew S, Krauter K, Sheinfeld J, Massague J, Cordon-Cardo C (1995) p27Kip1: chromosomal mapping to 12p12–12p13.1 and absence of mutations in human tumors. Cancer Res 55: 1121–1124
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory, Cold Spring Habor, NY
Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell cycle control causing specific inhibition of cyclinD/cdk4. Nature 366: 704–707
Sherr CJ (1994) G1 phase progression: cyclin on cue. Cell 79: 551–555
Shiohara M, El-Deity WS, Wada M, Nakamaki T, Takeuchi S, Yang R, Chen D-L, Vogelstein B, Koeffler HP (1994) Absence of WAF1 mutations in a variety of human malignancies. Blood 84:3781–3784
Sudo K, Chinen K, Nakamura Y (1994) 2058 expressed sequence tags (ESTs) from a human fetal lung cDNA library. Genomics 24:276–279
Takita K, Sato T, Miyagi M, Watatani M, Akiyama F, Sakamoto G, Kasumi F, Abe R, Nakamura Y (1992) Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes. Cancer Res 52: 3914–3917
Theillet C, Lidereau R, Escot C, Hutzell P, Brunet M, Gest J, Schlom J, Callahan R (1986) Loss of a c-II-ras-1 allele and aggressive human primary breast carcinomas. Cancer Res 46: 4776–4781
Tokino T, Takahashi E, Mori M, Tanigami A, Glaser T, Park JW, Jones C, Hori T, Nakamura Y (1991) Isolation and mapping of 62 new RFLP markers on human chromosome 11. Am J Hum Genet 48: 258–268
Toyoshima H, Hunter T (1994) p27, a novel inhibitor of G1 cyclin/cdk protein kinase activity, is related to p21. Cell 78: 67–74
Waga S, Hannon GJ, Beach D, Stillman B (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574–578
Xiong Y, Hannon GJ, Zang H, Casso D, Kobayashi R, Beach D (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366:701–704
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tokino, T., Urano, T., Furuhata, T. et al. Characterization of the human p57KIP2 gene: Alternative splicing, insertion/deletion polymorphisms in VNTR sequences in the coding region, and mutational analysis. Hum Genet 97, 625–631 (1996). https://doi.org/10.1007/BF02281873
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02281873